Your browser doesn't support javascript.
loading
Améliorer la réglementation du cannabis médical au Canada pour mieux servir les patients pédiatriques.
Huntsman, Richard J; Kelly, Lauren E; Alcorn, Jane; Appendino, Juan Pablo; Bélanger, Richard E; Crooks, Bruce; Finkelstein, Yaron; Gilpin, Andrea; Lewis, Evan; Litalien, Catherine; Jacobs, Julia; Moore-Hepburn, Charlotte; Oberlander, Timothy; Rassekh, S Rod; Repetski, Alexander E; Rieder, Michael J; Shackelford, Alan; Siden, Hal; Szafron, Michael; 't Jong, Geert W; Vaillancourt, Régis.
Afiliação
  • Huntsman RJ; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Kelly LE; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Alcorn J; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Appendino JP; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Bélanger RE; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Crooks B; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Finkelstein Y; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Gilpin A; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Lewis E; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Litalien C; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Jacobs J; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Moore-Hepburn C; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Oberlander T; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Rassekh SR; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Repetski AE; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Rieder MJ; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Shackelford A; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Siden H; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Szafron M; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • 't Jong GW; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
  • Vaillancourt R; Division de neurologie pédiatrique (Huntsman), Département de pédiatrie et Cannabinoid Research Initiative of Saskatchewan (Huntsman, Alcorn, Szafron, Shackelford), Université de la Saskatchewan, Saskatoon, Sask.; Consortium C4T (Canadian Childhood Cannabinoid Clinical Trial) (Kelly, Crooks, Finkels
CMAJ ; 193(48): E1864-E1867, 2021 12 06.
Article em Fr | MEDLINE | ID: mdl-34872964
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: Fr Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: Fr Ano de publicação: 2021 Tipo de documento: Article